Morgan Stanley sees “an opportune entry point” into Keurig Dr Pepper (KDP), arguing that the market not recognizing better near-term visibility than investor fears, as well as relative to consumer package goods peers, and building visibility of long-term organic sales growth outperformance has created a “very compelling valuation.” The firm’s 20% base case for upside is predicated mainly on continued strength in U.S. Refreshment/International, which are three-quarters of profit combined, notes the analyst, who has an Overweight rating and $40 price target on Keurig Dr Pepper shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Coca-Cola Partners With Universal Music to Debut Real Thing Records
- Keurig Dr Pepper Declares Quarterly Dividend Announcement
- Coca-Cola Embraces Viral TikTok Trend With Sprite+Tea
- Keurig Dr Pepper’s Strong Sales Growth and Promising Financial Outlook Earns Buy Rating
- Keurig Dr Pepper’s Strong U.S. Momentum and Strategic Investments Drive Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue